CompletedNot Applicable

Effects of an Interaction-Based Multi-Care Program on Postpartum Hemorrhage Recovery

China110 participantsStarted 2023-10-01

Plain-language summary

This study explored the impact of an interaction standard theory-based multi-care program on postpartum recovery, coping styles, psychological distress, and quality of life in women experiencing postpartum hemorrhage (PPH). A total of 110 women with PPH were randomized into a study group receiving the multi-care program or a control group receiving conventional nursing. Outcomes were assessed at baseline and 2 weeks post-intervention. The multi-care program significantly improved postpartum recovery, enhanced adaptive coping, reduced psychological distress, and improved quality of life compared to conventional care.

Who can participate

Age range

18 Years – 39 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Delivered in our hospital and received postpartum treatment, with a blood loss \>500 mL within 24 hours after delivery; * Age \<40 years; * Single live birth at full term; * Stable vital signs; * No pregnancy-related complications (other than PPH itself post-diagnosis); * Clear cognitive function and self-awareness; * Normal hearing and communication ability. Exclusion Criteria: * Cervical laceration (as primary cause of PPH if not manageable by standard protocol and requiring extensive surgical repair beyond typical scope); * Pre-existing severe cardiovascular diseases; * Pre-existing severe renal, cardiac, or hepatic insufficiency; * Known pre-existing coagulation disorders; * Active systemic infectious diseases; * Malignant tumors; * Cellular immune function defects; * Incomplete data or withdrawal from the study (prior to completion of the 2-week follow-up, though none occurred).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Coping Styles (Positive Coping)

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Change in Coping Styles (Negative Coping)

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Change in Depression Severity

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention (or 1 day before discharge if earlier).

Change in Anxiety Severity

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention (or 1 day before discharge if earlier).

Change in Quality of Life

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Duration of Lochia

Timeframe: Assessed up to 2 weeks post-intervention.

Time for Uterus to Return to Pelvic Cavity (Uterine Involution)

Timeframe: Assessed up to 2 weeks post-intervention.

Trial details

NCT IDNCT07058142

SponsorXingxing Lv

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Postpartum Hemorrhage trials

Plain-language summary

Who can participate

Age range

18 Years – 39 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Coping Styles (Positive Coping)

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Change in Coping Styles (Negative Coping)

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Change in Depression Severity

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention (or 1 day before discharge if earlier).

Change in Anxiety Severity

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention (or 1 day before discharge if earlier).

Change in Quality of Life

Timeframe: Baseline (1 day post-PPH event) and 2 weeks post-intervention.

Duration of Lochia

Timeframe: Assessed up to 2 weeks post-intervention.

Time for Uterus to Return to Pelvic Cavity (Uterine Involution)

Timeframe: Assessed up to 2 weeks post-intervention.